Valuation: Cutia Therapeutics

Market Cap 833M 963M 123M 108M 99.49M 91.79M 174M 11.72B 177M 1.19B 465M 5.75B 461M 451M 19.89B P/E 2026 *
-5x
P/E 2027 * 17.6x
Enterprise Value 901M 1.04B 133M 117M 108M 99.36M 188M 12.69B 192M 1.29B 504M 6.22B 499M 489M 21.53B EV / Sales 2026 *
1.4x
EV / Sales 2027 * 0.71x
Free-Float
35.23%
Yield 2026 *
-
Yield 2027 * -
1 day-1.49%
1 week-3.28%
Current month-6.36%
1 month-21.36%
3 months-42.52%
6 months-49.04%
Current year-41.63%
1 week 2.57
Extreme 2.57
2.88
1 month 2.57
Extreme 2.57
3.41
Current year 2.57
Extreme 2.57
5.51
1 year 2.57
Extreme 2.57
12
3 years 2.57
Extreme 2.57
31
5 years 2.57
Extreme 2.57
32.6
10 years 2.57
Extreme 2.57
32.6
Manager TitleAgeSince
Chief Executive Officer 48 01/09/2019
Director of Finance/CFO 36 10/05/2021
Chief Tech/Sci/R&D Officer 42 10/01/2020
Director TitleAgeSince
Chairman 63 23/08/2019
Director/Board Member 48 12/06/2023
Director/Board Member 57 30/12/2025
Date Insider Type Main position Quantity % Market Cap.
15/10/24Other

Founder

15,000 0.0049%
03/10/24Other

Chief Financial Officer

20,000 0.0066%
02/10/24Other

Chief Financial Officer

30,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
-1.49%-3.28%-69.43%-88.20% 123M
-2.33%-2.09%+49.88%+170.51% 1,060B
-0.82%-2.30%+63.79%+62.00% 619B
-0.73%-4.98%+28.91%+82.99% 438B
+0.33%-1.17%+31.07%+27.09% 333B
-0.02%-2.85%+29.15%+45.24% 282B
-3.89%-11.22%+22.81%+27.30% 267B
+0.66%-1.42%-26.59%-37.71% 218B
-0.06%-2.88%+23.07%+62.33% 196B
-3.72%-1.10%+18.41%+70.56% 161B
Average -1.21%-3.25%+17.11%+42.21% 357.4B
Weighted average by Cap. -1.31%-2.96%+36.75%+83.90%

Financials

2026 *2027 *
Net sales 646M 747M 95.32M 83.58M 77.16M 71.19M 135M 9.09B 137M 921M 361M 4.46B 358M 350M 15.42B 1.18B 1.36B 174M 153M 141M 130M 247M 16.6B 251M 1.68B 659M 8.15B 654M 639M 28.18B
Net income -146M -169M -21.51M -18.86M -17.41M -16.06M -30.46M -2.05B -30.98M -208M -81.43M -1.01B -80.74M -78.99M -3.48B 44.25M 51.19M 6.53M 5.73M 5.29M 4.88M 9.25M 623M 9.41M 63.12M 24.72M 306M 24.52M 23.98M 1.06B
Net Debt 68.7M 79.47M 10.14M 8.89M 8.21M 7.57M 14.36M 967M 14.6M 98M 38.39M 474M 38.06M 37.24M 1.64B -
Logo Cutia Therapeutics
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
Employees
304
Date Price Change Volume
10/07/26 HK$2.650 -1.49% 23,000
09/07/26 HK$2.690 +1.51% 37,800
08/07/26 HK$2.650 0.00% 9,600
07/07/26 HK$2.650 -5.69% 180,600
06/07/26 HK$2.810 +2.55% 8,800
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.292CNY
Average target price
9.801CNY
Spread / Average Target
+327.65%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2487 Stock